TOI
Oncology Institute Inc
6.20$
+20.9%
vs. previous close
Closing price · As of: Aug 11, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.8% | -10.1% | -4.5% | -16.8% | -15.9% | 0.8% | 4.2% | -4.8% | -8.5% | -9.2% | 2.3% | -1.5% | -4.0% | |
| 1.7% | 2.1% | 1.8% | 1.6% | 1.5% | 1.6% | 1.7% | 1.7% | 1.5% | 1.3% | -1.3% | 1.1% | 0.6% | |
| 5.1% | 5.7% | 4.8% | 4.3% | 3.4% | 2.4% | 1.3% | 1.4% | 0.6% | 0.7% | -0.6% | 1.1% | 0.5% | |
| 4.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.2% | -1.4% | 7.5% | -2.9% | -3.5% | 11.5% | 12.7% | 3.0% | -2.7% | -4.5% | 5.4% | 0.6% | -0.2% | |
| 1.2% | 1.1% | 1.0% | 0.6% | 1.9% | 0.4% | 1.8% | 0.3% | 1.0% | 0.4% | 0.7% | 0.7% | 0.7% | |
| 31.0% | 9.4% | 13.6% | 20.5% | 18.4% | 10.4% | -1.8% | -0.2% | -1.0% | -0.4% | -0.7% | -0.7% | -0.7% | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| -1.1% | -0.2% | 0.0% | – | – | 0.0% | 0.0% | – | – | – | – | – | – | |
| -1.7% | – | – | – | – | 0.0% | 0.0% | -19.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -3.2% | -0.9% | -2.1% | -1.0% | -2.2% | -0.2% | -0.2% | -4.5% | 1.6% | 7.8% | 2.6% | 0.0% | 3.0% | |
| 17.0% | -1.7% | 6.9% | 2.7% | 0.4% | 11.0% | 2.3% | -9.5% | -7.9% | -1.9% | 4.2% | -2.2% | -1.7% | |
| -12.0% | -11.3% | -5.5% | -17.4% | -17.7% | 1.2% | 2.4% | -5.1% | -9.5% | -9.7% | 1.5% | -2.2% | -4.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.